Search Share Prices
AZN Shares - Broker Forecast - Bryan Garnier issues a broker note on AstraZeneca PLC
Bryan Garnier today reaffirms its buy investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 8780p (from 8550p).
AstraZeneca reports positive progress of cancer drugs in US; recovers rights of brazikumab from Allergan
Pharma giant AstraZeneca reported positive news on the progress of its gastric and ovarian cancer drugs in the US. The company also said it had completed the recovery of the global rights to antibody ...
AstraZeneca receives US approval for a combination with Lynparza in advanced ovarian cancer
The firm also announced it completed the recovery of global rights to brazikumab while its candidate Enhertu received a fast-track designation ...
AstraZeneca says Farxiga heart drug receives US green light
Farxiga has been shown to reduce the risk of death and hospitalisation for cardiovascular patients with a condition called reduced ejection fraction ...
Stocks - Europe Edges Lower; FTSE 100 Outperforms
European stock markets traded slightly lower Wednesday amid weak economic data, while better than expected earnings helped the U.K. to outperform. At 4:35 AM ET (0835 GMT), the DAX in Germany traded 0 ...